Vignette study for Treatment Selection in Patients with Non-small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations (LOGIK-0903)
Not Applicable
- Conditions
- on-Small-Cell Lung Cancer
- Registration Number
- JPRN-UMIN000003523
- Lead Sponsor
- ung Oncology Group in Kyushu, Japan (LOGIK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have previously treated with standard platinum doublet chemotherapy, single chemotherapy for elderly or EGFR-TKI
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate the reason for treatment selection by patients, physician or medical staff.
- Secondary Outcome Measures
Name Time Method To investigate any correlation between patient treatment choice and FACT-L or HADS To explore any gap in treatment choice between patients and physicians or medical staff.